The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

On July 1, Robert A. Michael assumed the role of chief executive officer. Michael succeeds Richard A. Gonzalez, who had held the role since 2013, when AbbVie spun off from Abbott Laboratories ...

and we strengthened our business through strategic transactions," said Robert A. Michael, CEO of AbbVie. "We are entering 2025 with significant momentum and expect net revenues to exceed their ...

offering a compelling opportunity based on the potential to address patient needs while also fostering long-term growth for ...

STAT News wrote the agreement happened less than a year after Robert Michael became AbbVie’s CEO. It also comes after the patent for AbbVie’s autoimmune medicine, Humira, expires.

"At AbbVie, we are focused on transforming the future of patient care in areas where significant unmet need persists," said Robert A. Michael, chief executive officer, AbbVie. "Our partnership ...

"We would be certainly thoughtful, we can commit less capital, particularly in psych, but it doesn't change our willingness to take calculated risks," AbbVie CEO Robert Michael said Wednesday at ...

offering a compelling opportunity based on the potential to address patient needs while also fostering long-term growth for ...